Novinky v patogenezi a léčbě psoriázy
| Title in English | News in pathogenesis and therapy of psoriasis |
|---|---|
| Authors | |
| Year of publication | 2020 |
| Type | Article in Periodical |
| Magazine / Source | Medicína po promoci |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.tribune.cz/clanek/45675-novinky-v-patogenezi-a-lecbe-psoriazy |
| Keywords | psoriasis; pathophysiology; therapy; news; carrier systems |
| Description | Psoriasis is a chronic inflammatory skin disease that affects 2-3% of the population. Psoriasis is divided according to phenotype into several forms, depending on severity, to mild, medium and severe form. Depending on the severity and co-morbidities, treatment of the disease is chosen. The treatment options include local treatment, phototherapy, systemic treatment and, most recently, biological treatment. With the development and application of new molecules, respectively. monoclonal antibodies significantly increase the cost of treatment, but also patient satisfaction with the outcome of treatment in very severe forms of the disease. Development also continues with local treatment. New carrier systems have been investigated and developed. They efficiently transport active agents through the skin barrier and allow highly effective topical treatment of psoriasis. |